1. Press Release

Press Release

Three Lovelace Hospitals Nationally Recognized with an ‘A’ Leapfrog Hospital Safety Grade

FOR IMMEDIATE RELEASE

ALBUQUERQUE, April 29, 2021 — Lovelace Medical Center (LMC), Lovelace Women’s Hospital (LWH) and Lovelace Regional Hospital (LRH) received an “A” safety grade in the spring 2021 Leapfrog Hospital Safety Grade report, a national distinction recognizing their achievements protecting patients from errors, injuries, accidents, and infections. This is the second safety grade “A” in a row for both LMC and LWH.

Lovelace Health System Now Offering Highly Advanced Robotic-Arm Assisted Joint Replacement

FOR IMMEDIATE RELEASE

The only hospital in Albuquerque offering Stryker’s Mako Smartrobotics™


ALBUQUERQUE – April 22, 2021 – Lovelace Medical Center and Lovelace Westside Hospital are the first hospitals in Albuquerque to offer patients new orthopedic robotic technology that has shown to decrease pain post-surgery, shorten hospital stays and improve flexibly as compared to manual surgery.

Lovelace Women’s Hospital Names Amy Blasing as Chief Executive Officer

FOR IMMEDIATE RELEASE

ALBUQUERQUE – March 22, 2021 – Lovelace Health System has named Amy Blasing, RN, MSN as the chief executive officer (CEO) of Lovelace Women’s Hospital, effective April 5, 2021.

Lovelace Women’s Hospital Offering Single Dose Radiation Therapy to Treat Breast Cancer

FOR IMMEDIATE RELEASE

ALBUQUERQUE – February 8, 2021 – Lovelace Women’s Hospital is now performing single-dose radiation therapy for breast cancer that demonstrates the same efficacy as traditional 6-week radiotherapy and is significantly more convenient and less stressful for patients. Calvin Ridgeway, MD, a surgical oncologist, now performs the procedure at Lovelace Women’s Hospital, the only hospital in New Mexico offering this Targeted Intraoperative Radiotherapy (TARGIT-IORT) using the Intrabeam® System from ZEISS.

Heart Hospital of New Mexico at Lovelace Medical Center Announces Patient Enrollment in its iCLAS™ U.S. IDE Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Persistent Atrial Fibrillation

FOR IMMEDIATE RELEASE

ALBUQUERQUE – January 5, 2021 – Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) is now enrolling patients in the iCLAS™ U.S. IDE Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Persistent Atrial Fibrillation. The iCLAS catheter device cuts hours off an ablation procedure, leading to a better outcome and faster recovery time for the patient. HHNM is the only site in New Mexico offering this advanced procedure, performed by New Mexico Heart Institute/Lovelace Medical Group electrophysiologists.

Lovelace Medical Center and Heart Hospital of New Mexico at Lovelace Medical Center name Derrick Cuenca as chief executive officer

FOR IMMEDIATE RELEASE

 

ALBUQUERQUE – December 4, 2020 – Lovelace Health System welcomes Derrick Cuenca, FACHE, as the chief executive officer (CEO) of Lovelace Medical Center and Heart Hospital of New Mexico at Lovelace Medical Center, effective December 7.

Lovelace Women’s Hospital receives the Award for Excellence in Lactation Care

FOR IMMEDIATE RELEASE

ALBUQUERQUE – November 10, 2020 – Lovelace Women’s Hospital was recognized for excellence in lactation care by the International Board of Lactation Consultant Examiners® (IBLCE®) and International Lactation Consultant Association ® (ILCA®), the only hospital in the state of New Mexico to earn this award.

Heart Hospital of New Mexico at Lovelace Medical Center and Lovelace Westside Hospital receive American Heart Association “Get With The Guidelines” Awards

FOR IMMEDIATE RELEASE

ALBUQUERQUE – November 9, 2020 – Heart Hospital of New Mexico at Lovelace Medical Center (Heart Hospital) has received the American Heart Association’s Get With The Guidelines®-Heart Failure Gold Plus with Honor Roll Quality Achievement Award, the Get With The Guidelines® - Stroke GOLD PLUS with Honor Roll Elite and Target: Type 2 Diabetes Honor Roll, both for the eighth consecutive year. Lovelace Westside Hospital received American Heart Association’s Get With The Guidelines® - Stroke Silver with Target: Type 2 Diabetes.

Lovelace Women’s Hospital nationally recognized as a Best Maternity Care Hospital by Newsweek

FOR IMMEDIATE RELEASE

ALBUQUERQUE – September 23, 2020 – Lovelace Women’s Hospital was named to Newsweek’s 2020 list of Best Maternity Care Hospitals. The distinction recognizes facilities that have excelled in providing care to mothers, newborns and their families, as verified by the 2019 Leapfrog Hospital Survey. Best Maternity Care Hospitals is part of Newsweek’s Best Health Care series, powered by data from The Leapfrog Group.

Lovelace Medical Group primacy clinics earn Patient-Centered Medical Home Recognition from NCQA

FOR IMMEDIATE RELEASE

ALBUQUERQUE, September 2, 2020 –– Lovelace Medical Group’s primary care clinics have completed the National Committee for Quality Assurance Patient-Centered Medical Home (PCMH) Re-recognition, exemplifying our commitment to the delivery of high-quality care with evidence-based, nationally recognized clinical standards of care. The PCMH guiding principles have been the model for care delivery at Lovelace Medical Group (LMG) since 2016, when LMG was first received PCMH recognition.